Anavex Life Sciences Corp (AVXL)

[TempePhil]

Early approval if new trial responses follows 148wk curve?

Since a2-73 seems to be a significant improvement over SOC and biibs BAN, does anyone with trial experience think the new trial, with larger sample set, will get earlier approval if the larger sample set follows the 148 wk curve? It seems like the response is now fairly well defined for a2-73, the main complaint being sample size and placebo. So if a larger set tracks similarly for even a few months, would this be enough to affect early approval?